RecruitingNot ApplicableNCT06629272

Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing

Sponsor

University of Michigan

Enrollment

900 participants

Start Date

Dec 2, 2024

Study Type

INTERVENTIONAL

Conditions

Hypothyroidism

Summary

The proposed study focuses on testing a novel adapted evidence-based multilevel intervention, Deprescribing Thyroid Hormone In Older Adults (D-THIO), to support thyroid hormone deprescribing (dose de-escalation and/or discontinuation) in older adults with thyroid hormone overtreatment and/or misuse and reduce patient harm. Findings from this study will lay the groundwork for broad implementation of D-THIO and serve as a model for deprescribing inappropriate medications for other endocrine conditions and conditions with biochemical monitoring.

Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called D-THIO (Deprescribing Thyroid Hormone In Older Adults) and a behavioral approach called Enhanced usual care for people with hypothyroidism. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALD-THIO (Deprescribing Thyroid Hormone In Older Adults)

D-THIO consists of evidence-based pharmaceutical opinion letters to providers advising deprescribing for their patients 65 years and older with thyroid hormone overtreatment/misuse and EMPOWER ("Eliminating Medications through Patient Ownership of End Results") brochures to their patients.

BEHAVIORALEnhanced usual care

American Thyroid Association \[ATA\] provider guidelines, ATA patient brochure